UNSPSC 51172474: Lansoprazole/naproxen

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA900. This VA Drug Class (GA900) classifies this compound as belonging to the group GASTRIC MEDICATIONS, OTHER.

UNSPSC 51172474 Lansoprazole/naproxen is a Commodity code tracking a single pharmaceutical product line, but recent state and local procurement activity tagged under it spans much broader pharmaceutical and testing services with minimal direct connection to the named drug. The code appears in three recent solicitations: Collin County Community Supervision and Corrections Department's RFP for offender specimen collection and drug testing services (posted July 9, 2026, due July 23, 2026), the Texas Health and Human Services Commission's Request for Information on a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program (posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026, due March 26, 2026). The Collin County work encompasses staffing two collection sites, operating an Interactive Voice Response system, conducting immunoassay screening with LC/MS/MS or GC/MS confirmation, and providing alternative testing methodologies including oral fluid and hair testing, with an estimated contract value of $600,000 over two years plus three optional one-year renewals. The MMCAP cooperative purchasing vehicle solicits manufacturers to supply generic pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, requiring cGMP and DSCSA compliance, $5 million commercial general liability coverage, and pricing submissions through authorized wholesalers AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.

The issuing bodies span a county corrections department, a state health agency, and a multi-state cooperative purchasing organization, indicating fragmented procurement across criminal justice, health and human services, and group purchasing functions. Geographic activity centers on Texas (Collin County RFP and HHS Commission RFI) and Minnesota-Oregon (MMCAP RFP), with no additional states represented in the recent opportunities block. The disconnect between the code's nominal scope — a specific pharmaceutical product — and the actual solicitations (drug testing services and broad pharmaceutical supply categories) suggests the code may be misapplied in state and local systems or that the recent opportunities carry incorrect coding. The most concrete near-term opportunity is Collin County's award decision on August 10, 2026, with contract commencement September 1, 2026; MMCAP's effective date is July 1, 2026, following March 26, 2026 proposal submission. The Texas HHS RFI represents an exploratory information-gathering phase with no binding timeline, budget, or award parameters disclosed.